Hormone replacement therapy explained: A modern guide to menopause care

Introduction: HRT has changed since the old headlines

If your understanding of hormone replacement therapy comes from headlines two decades ago, it's worth an update. The 2002 Women's Health Initiative study led many people to stop HRT and many clinicians to hesitate to prescribe it, but the years since have added important nuance to what that study actually showed. Major medical organizations, including menopause and endocrine societies, have since described HRT as an appropriate option for many people with menopause symptoms, particularly when started nearer to the onset of menopause. Whether it's appropriate for you is an individual clinical question.

This is an educational overview. It isn't medical advice or a promise of a specific result.

Why the old fears need context

Much of the lingering worry about HRT traces to early coverage of one study. Later analyses added important nuance: the risk picture depends on the type of hormone used, the route it's delivered by, and how close to menopause treatment begins. The regimens studied then are not identical to the bioidentical estradiol and micronized progesterone more commonly used now, and starting nearer to the onset of menopause is generally discussed as having a more favorable balance than starting many years later.

This is a summary of how the conversation has evolved, not a safety guarantee. What it means for you is a discussion to have with a licensed provider, informed by your own history rather than by a headline.

What happens during menopause

Menopause is a transition, not a single event. It begins in perimenopause, usually in the mid-40s, when the ovaries gradually produce less estrogen and progesterone and hormone levels fluctuate. Menopause is reached after 12 consecutive months without a period, typically around age 51, after which estrogen levels remain consistently low.

Estrogen has receptors throughout the body, so its decline can affect many systems, which is why menopause symptoms vary so widely. Commonly discussed ones include hot flashes and night sweats (vasomotor symptoms), vaginal dryness and urinary changes (genitourinary symptoms), disrupted sleep, mood changes, and changes in bone health over the longer term. Testosterone levels also shift with age and are part of the picture for some people. Describing this is biology, not a claim about what any treatment will do.

The main categories of options

Modern menopause care isn't one-size-fits-all, and neither is the set of options a provider might consider.

• Systemic estradiol is used for whole-body symptoms and comes as tablets, cream, or patches. Oral and transdermal (skin) routes are absorbed differently, and that difference is one factor a provider weighs, since oral estrogen is associated with a higher clotting risk than transdermal routes.
• Vaginal estradiol is a localized form (gel or tablets) used for vaginal and urinary symptoms, with low absorption into the rest of the body, so it's sometimes used on its own or alongside a systemic form.
• Progesterone matters for anyone using systemic estrogen who still has a uterus: it's added to protect the uterine lining, and that is a standard part of how these regimens are designed.
• Testosterone is used in some cases, particularly for low libido in postmenopausal people. In the United States there is no FDA-approved testosterone product specifically for women, so it's prescribed off-label or as a compounded formulation, at doses much lower than those used in men.
• Non-hormonal medications, such as paroxetine and desvenlafaxine, are options for people who can't or prefer not to use estrogen. Some of the medications above are compounded and not FDA-approved, and a provider explains that status before prescribing.

Who it's generally considered for

HRT is often discussed for people with moderate to severe hot flashes or night sweats, genitourinary symptoms, early or premature menopause, or elevated risk of bone loss. Being in one of these groups doesn't mean HRT is right for you; it means it's worth discussing with a provider.

Some conditions make systemic estrogen inappropriate or call for careful evaluation, including a known or suspected estrogen-dependent cancer, a history of blood clots, stroke, or heart attack, undiagnosed vaginal bleeding, or active liver disease. Others, such as a family history of breast cancer or a personal history of clots, call for a careful discussion rather than an automatic no. This is exactly what a provider reviews before recommending anything.

How a plan comes together

Because symptoms and health histories differ, a plan is built around the individual and adjusted over time. A licensed provider reviews your symptoms, menopause stage, health history, and preferences to determine what's appropriate. Delivery method, dose, and whether to combine a systemic and a local form can all be adjusted as your situation changes, and for people with contraindications to estrogen, non-hormonal options can be discussed.

Common questions

Is HRT safe?

Whether it's appropriate depends on your health history, your menopause stage, and the formulation and route used. That individual assessment, rather than a blanket yes or no, is the point of talking with a provider.

Is "bioidentical" the same as "natural" or safer?

Bioidentical simply means chemically identical to the hormones the body makes, and regulated bioidentical estradiol and progesterone are widely used. It isn't a synonym for unregulated compounded products, and it isn't a safety guarantee on its own.

Do I have to take HRT forever?

No. Duration is individual and revisited over time with a provider, based on your symptoms, your health history, and your preferences.

What if I can't take estrogen?

Non-hormonal medications such as paroxetine and desvenlafaxine are options a provider may consider. For some people, localized vaginal estradiol is discussed separately because its absorption into the rest of the body is low, but whether any estrogen-containing option is appropriate is always an individual clinical decision, especially with a history of hormone-sensitive conditions.

Explore Luvo's Hormone Replacement Program to learn more.